| 000 | nam a22 a 4500 | ||
|---|---|---|---|
| 999 |
_c20441 _d20441 |
||
| 001 | BD-DhNSU-20441 | ||
| 003 | BD-DhNSU | ||
| 005 | 20190403064240.0 | ||
| 008 | 190403s1987 nyua|||g |||| 001 0|eng d | ||
| 010 | _a | ||
| 020 | _a0824775236 | ||
| 040 |
_aDLC _cDLC _dBD-DhNSU |
||
| 041 | _aeng | ||
| 050 | 0 | 0 |
_aRM301.4 _b.N67 1987 |
| 100 | 1 | _aNotari, Robert E. | |
| 245 | 0 | 0 |
_aBiopharmaceutics and clinical pharmacokinetics : _ban introduction / _cRobert E. Notari |
| 250 | _a4th ed. | ||
| 260 |
_aNew York : _bMarcel Dekker, _cc1987. |
||
| 300 |
_axx, 416 p. : _bill. ; _c24 cm. |
||
| 650 | 0 | _aBiopharmaceutics | |
| 650 | 4 | _aPharmacokinetics | |
| 650 | 4 | _aBiopharmaceutics | |
| 942 |
_2lcc _cBK |
||